AstraZeneca Pharma India Ltd. — Audit Report / Information 2021

May 26, 2021

==> picture [503 x 87] intentionally omitted <==

May 26, 2021

The Manager – Listing BSE Limited , 1[st] Floor, New Trading Ring Rotunda Buiding, P J Towers, Dalal Street, Fort, Mumbai 400001

The Manager – Listing National Stock Exchange of India Ltd. Exchange plaza, 5[th] Floor, Plot No.C/1, G Block Bandra‐Kurla Complex, Bandra (E), Mumbai 400051

Dear Sir(s),

Reappointment of Statutory Auditors for Second Term

Ref: Scrip Code ‐ BSE: 506820 / NSE: ASTRAZEN

The Board of Directors of the Company at their meeting held on May 25, 2021, have, inter alia, approved the Re‐appointment of M/s. Price Waterhouse & Co. Chartered Accountants LLP (ICAI Firm Registration No.304026E/E‐300009), as the Statutory Auditors of the Company for a second term of five (5) years, subject to the approval of the shareholders at the ensuing Annual General Meeting (AGM), to hold office from the conclusion of 42[nd] AGM till the conclusion of 47[th] AGM.

The Company has received the certificate of eligibility in accordance with Sections 139, 141 and other applicable provisions, if any of the Companies Act, 2013 read with the Rules issued thereunder, from M/s. Price Waterhouse & Co. Chartered Accountants LLP.

We request you to please take the same on record.

Thanking you,

For AstraZeneca Pharma India Limited

PRATAP Digitally signed by PRATAP RUDRA RUDRA BHUVANAG BHUVANAGIRI Date: 2021.05.26 IRI 11:25:39 +05'30'

Pratap Rudra Company Secretary & Legal Counsel

==> picture [452 x 64] intentionally omitted <==